The Scientist - Home

One of the most eminent and controversial scientists of this century, nuclear physicist Edward Teller is perhaps best known for his role in the development of nuclear weapons at Los Alamos National Laboratory during World War II. Often called the “father of the hydrogen bomb,” he also played a controversial role in the loss of security clearance by J. Robert Oppenheimer, the former director of Los Alamos. More recently Teller has been an outspohen advocate of defensive weap- ons, in

Ever since I first became involved in research in 1932 I have been struck by the difference in quality of the thinking of even quite emi- nent scientists when they apply their minds, on the one hand, to their own specialized subjects and, on the other hand, to affairs of everyday life. Nor am I restricting my comments to the phenomenon of the distinguished Fellow of the Royal Society at the peak of a creative career who shows himself in committee to lack common sense, to say the least, when c

BELFAST—The strengths and opportunities within British academic research are being offered to industry, government agencies and scientists as part of a national academic data base created last year. The information, known as British Expertise in Science and Technology (BEST), was developed by the publishing firm Longman Cartermill, at the University of St. Andrew’s. Set up in March 1986, BEST covers 180 institutions and contains 14,000 records of scientists and their work. Michae

SAO PAULO—An international group of chemistry educators has recommended greater contact between working scientists and educators as part of an effort to improve public understanding of science. Delegates to the Ninth International Conference on Chemistry Education held here this summer suggested that scientists involve themselves in communicating news about their work to audiences beyond their professional groups. A conference resolution declared that national scientific bodies should

The first reporter on the scene of the Chernobyl accident in late April 1986 was Vladimir Gubaryev. He later wrote a play about the incident, excerpted here.

WASHINGTON—The Howard Hughes Medical Institute (HHMI) next month will announce a $40 million-a-year program ranging from support for graduate training in the biomedical sciences to funding of health policy and cost-containment studies. Purnell Choppin, HHMI’s former vice president and chief scientific officer who was appointed president of the institute on September 1, said the education prograin will include funds to upgrade science departments at undergraduate colleges and sup

WASHINGTON---The decision by Cray Research Inc. to abandon development of its most advanced supercomputer project has dealt a blow to the U.S. supercomputer industry and may set back researchers in the 1990s, say some specialists in the field. “I think the United States has lost one of its very serious efforts in supercomputing,” said Lawrence Lee, director of the Cornell National Supercomputer Facility in Ithaca, N.Y, who added that the step may have “serious repercussion

TOWNSVILLE, AUSTRALIA—The Australian scientific community is struggling to come to terms with its diminished political influence following the abrupt abolition of the Department of Science as part of a massive restructuring of federal departments after the national election July 11. “The science lobby, such as it is, has been neutered,” commented Ian Lowe of Griffith University, an expert on Australian science policy, who also described “a high level of confusion in t

ZURICH—Officials at Glaxo, the British pharmaceutical giant that has agreed to purchase the Geneva research laboratory of Biogen N.Y., have promised that the facility will retain a degree of autonomy as an intemational center of excellence in biotechnology. John Barr, a spokesman for Glaxo, said that the laboratory will be integrated into the company’s general research program and renamed the Glaxo Institute for Molecular Biology. The new director of research will be Allan Will

WEST BERLIN—The forging of stronger ties among researchers, and between academia and industry, are two important goals of this city’s new Academy of Science (see THE SCIENTIST, March 9, p. 5). The academy, after opening ceremonies later this week, will begin work on a research agenda that will span the natural and medical sciences as well as technology assessment. The first six projects, chosen from 39 proposals and each expected to last three years, will cover automation and the

CAMBRIDGE, U.K.—The former director of the Plant Breeding Institute here has endorsed the government’s selection of Unilever as the new owner of the facility. The sale of the PBI and the National Seed Development Organization is part of Prime Minister Thatcher’s strategy to privatize many government-owned companies and institutions. The PBI is the country’s major institute for research on plant breeding, and the NSDO earned nearly $7 million last year by marketing se

WASHINGTON—In many areas of science or technology—from climate changes to new manufacturing technology—the lines between science and foreign policy blur and sometimes disappear. “Things that used to be domestic aren’t any more,” said Robert W. Rycroft, deputy director of the graduate program in science, technology and public policy at George Washington University and an associate professor of public affairs and political science. “There are severe i